• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿重症监护病房的血流感染:文献系统综述

Bloodstream Infections in the Neonatal Intensive Care Unit: A Systematic Review of the Literature.

作者信息

Vogiantzi Georgia, Metallinou Dimitra, Tigka Maria, Deltsidou Anna, Nanou Christina I

机构信息

Department of Midwifery, Faculty of Health and Care Sciences, University of West Attica, Athens, GRC.

Department of Midwifery, General and Maternity Hospital "Helena Venizelou", Athens, GRC.

出版信息

Cureus. 2024 Aug 28;16(8):e68057. doi: 10.7759/cureus.68057. eCollection 2024 Aug.

DOI:10.7759/cureus.68057
PMID:39347186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11438544/
Abstract

Bloodstream infections represent a significant concern in neonatal intensive care units (NICUs), constituting a leading cause of morbidity and mortality among neonates. This study aimed to elucidate the etiology, prevalence, and antimicrobial resistance patterns of bloodstream infections in NICU settings. A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines using the PubMed database to source relevant studies published between 2019 and 2023. Keywords related to bloodstream infections, neonates in NICUs, pathogens, resistance, and susceptibility were employed. Out of the 73 identified articles, eight met the inclusion criteria. Findings revealed a predominance of late-onset sepsis in hospitalized neonates, with , , coagulase-negative staphylococci, Group B , species, , , and being the most commonly isolated pathogens. Antimicrobial susceptibility profiles demonstrated resistance among bacteria to ampicillin, gentamicin, and penicillin, while fungi exhibited resistance to amphotericin B, fluconazole, flucytosine, itraconazole, and voriconazole. These findings underscore the persistent challenge of bloodstream infections in the NICUs, particularly late-onset sepsis, emphasizing the importance of early detection and appropriate antimicrobial therapy in neonatal care management.

摘要

血流感染是新生儿重症监护病房(NICU)中的一个重大问题,是新生儿发病和死亡的主要原因之一。本研究旨在阐明NICU环境中血流感染的病因、患病率和抗菌药物耐药模式。根据系统评价和Meta分析的首选报告项目(PRISMA)声明指南,使用PubMed数据库进行了一项系统评价,以获取2019年至2023年期间发表的相关研究。使用了与血流感染、NICU中的新生儿、病原体、耐药性和敏感性相关的关键词。在73篇已识别的文章中,有8篇符合纳入标准。研究结果显示,住院新生儿中晚发性败血症占主导地位,凝固酶阴性葡萄球菌、B组链球菌、大肠杆菌、肺炎克雷伯菌、铜绿假单胞菌和白色念珠菌是最常分离出的病原体。抗菌药物敏感性分析表明,细菌对氨苄西林、庆大霉素和青霉素耐药,而真菌对两性霉素B、氟康唑、氟胞嘧啶、伊曲康唑和伏立康唑耐药。这些发现强调了NICU中血流感染,尤其是晚发性败血症的持续挑战,突出了新生儿护理管理中早期检测和适当抗菌治疗的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f4e/11438544/2c9182ec0c2f/cureus-0016-00000068057-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f4e/11438544/0eb8263ded2c/cureus-0016-00000068057-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f4e/11438544/2c9182ec0c2f/cureus-0016-00000068057-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f4e/11438544/0eb8263ded2c/cureus-0016-00000068057-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f4e/11438544/2c9182ec0c2f/cureus-0016-00000068057-i02.jpg

相似文献

1
Bloodstream Infections in the Neonatal Intensive Care Unit: A Systematic Review of the Literature.新生儿重症监护病房的血流感染:文献系统综述
Cureus. 2024 Aug 28;16(8):e68057. doi: 10.7759/cureus.68057. eCollection 2024 Aug.
2
Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.新生儿败血症中细菌病原体的分布特征及耐药性的文献综述。
J Matern Fetal Neonatal Med. 2022 Mar;35(5):861-870. doi: 10.1080/14767058.2020.1732342. Epub 2020 Feb 26.
3
Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017-2019.2017-2019 年中国 25 家新生儿重症监护病房血流感染的病原菌分布及耐药性分析。
Antimicrob Resist Infect Control. 2021 Aug 16;10(1):121. doi: 10.1186/s13756-021-00989-6.
4
Gram-negative bacilli associated with catheter-associated and non-catheter-associated bloodstream infections and hand carriage by healthcare workers in neonatal intensive care units.与新生儿重症监护病房中与导管相关和非导管相关血流感染以及医护人员手部携带相关的革兰氏阴性杆菌。
Pediatr Crit Care Med. 2005 Jul;6(4):457-61. doi: 10.1097/01.PCC.0000163669.37340.91.
5
Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.肠道革兰氏阴性杆菌血流感染:新生儿重症监护病房17年的经验
Am J Infect Control. 2004 Jun;32(4):189-95. doi: 10.1016/j.ajic.2003.07.004.
6
Bloodstream infections and antimicrobial resistance patterns in a South African neonatal intensive care unit.南非新生儿重症监护病房的血流感染及抗菌药物耐药模式
Paediatr Int Child Health. 2014 May;34(2):108-14. doi: 10.1179/2046905513Y.0000000082. Epub 2013 Dec 6.
7
Bacterial etiology and antimicrobial resistance pattern of pediatric bloodstream infections: a 5-year experience in an Iranian referral hospital.儿科血流感染的细菌病因学和抗菌药物耐药模式:伊朗转诊医院的 5 年经验。
BMC Infect Dis. 2024 Apr 3;24(1):373. doi: 10.1186/s12879-024-09260-w.
8
Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program.新生儿重症监护病房的血流感染:抗生素控制计划的12年经验
Infect Control Hosp Epidemiol. 1999 Apr;20(4):242-6. doi: 10.1086/501619.
9
Phenotypic bacterial epidemiology and antimicrobial resistance profiles in neonatal sepsis at Jimma medical center, Ethiopia: Insights from prospective study.埃塞俄比亚吉马医疗中心新生儿败血症的表型细菌流行病学和抗菌药物耐药性概况:前瞻性研究的见解
PLoS One. 2024 Sep 16;19(9):e0310376. doi: 10.1371/journal.pone.0310376. eCollection 2024.
10
Neonatal sepsis in a tertiary unit in South Africa.南非一家三级医院的新生儿败血症。
BMC Infect Dis. 2021 Feb 27;21(1):225. doi: 10.1186/s12879-021-05869-3.

引用本文的文献

1
Unveiling spp. in the Neonatal Intensive Care Unit: Clinical Impacts and Antibiotic Resistance.新生儿重症监护病房中揭开 spp. 的面纱:临床影响与抗生素耐药性
Antibiotics (Basel). 2025 Mar 3;14(3):259. doi: 10.3390/antibiotics14030259.

本文引用的文献

1
Antimicrobial Stewardship: A Correct Management to Reduce Sepsis in NICU Settings.抗菌药物管理:降低新生儿重症监护病房脓毒症的正确管理方法。
Antibiotics (Basel). 2024 Jun 3;13(6):520. doi: 10.3390/antibiotics13060520.
2
A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E).一种评估暴露效应非随机随访研究偏倚风险的工具(ROBINS-E)。
Environ Int. 2024 Apr;186:108602. doi: 10.1016/j.envint.2024.108602. Epub 2024 Mar 24.
3
Joining Forces against Antibiotic Resistance: The One Health Solution.
联合起来对抗抗生素耐药性:“同一健康”解决方案
Pathogens. 2023 Aug 23;12(9):1074. doi: 10.3390/pathogens12091074.
4
Infant isolation and cohorting for preventing or reducing transmission of healthcare-associated infections in neonatal units.婴儿隔离和分组以预防或减少新生儿单位中与医护相关的感染传播。
Cochrane Database Syst Rev. 2023 Jun 27;6(6):CD012458. doi: 10.1002/14651858.CD012458.pub2.
5
Implementation of Antimicrobial Stewardship in the Healthcare Setting.医疗机构中抗菌药物管理的实施
Cureus. 2022 Jul 8;14(7):e26664. doi: 10.7759/cureus.26664. eCollection 2022 Jul.
6
Clinical Laboratory Features of Microbes That Cause Neonatal Sepsis: An 8-Year Retrospective Study.引起新生儿败血症的微生物的临床实验室特征:一项8年回顾性研究
Infect Drug Resist. 2022 Jun 9;15:2983-2993. doi: 10.2147/IDR.S367068. eCollection 2022.
7
Neonatal sepsis-causing bacterial pathogens and outcome of trends of their antimicrobial susceptibility a 20-year period at a neonatal intensive care unit.新生儿重症监护病房20年间引起新生儿败血症的细菌病原体及其抗菌药物敏感性趋势的结果
Clin Exp Pediatr. 2022 Jul;65(7):350-357. doi: 10.3345/cep.2021.00668. Epub 2021 Dec 9.
8
Neonatal sepsis in Sana'a city, Yemen: a predominance of Burkholderia cepacia.也门萨那市新生儿败血症:洋葱伯克霍尔德菌占优势。
BMC Infect Dis. 2021 Oct 27;21(1):1108. doi: 10.1186/s12879-021-06808-y.
9
Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017-2019.2017-2019 年中国 25 家新生儿重症监护病房血流感染的病原菌分布及耐药性分析。
Antimicrob Resist Infect Control. 2021 Aug 16;10(1):121. doi: 10.1186/s13756-021-00989-6.
10
Hand hygiene for the prevention of infections in neonates.预防新生儿感染的手部卫生。
Cochrane Database Syst Rev. 2021 Jul 6;7(7):CD013326. doi: 10.1002/14651858.CD013326.pub3.